Ranking
Sterne Kessler Recognized for Patent Litigation and Prosecution
2024 LMG Life Sciences
Read More
Ranking
Sterne Kessler Ranked Best Performing Law Firm for Appellees
Patexia 2024 CAFC Intelligence Report
Read More
Award
Sterne Kessler Awarded “Top Workplace” for the 12th Consecutive Year
The Washington Post
Read MoreFeatured Experience
PTAB Trials: IPRs, PGRs, DERs
Sterne Kessler’s PTAB Trials team is deeply experienced in all proceedings at the PTAB, including inter partes reviews (IPRs), post-grant reviews (PGRs), and derivation proceedings (DERs). We emerged as a leader at the inception of the PTAB, and continue to be a dominant force in the industry today. We are among the top 10 most active firms at the PTAB, representing petitioners and patent owners across all technologies, including biotechnology, electronics, consumer products, automotive, and many others.
Artificial Intelligence
In the rapidly evolving world of artificial intelligence (AI), safeguarding your intellectual property (IP) is critical. As a market and thought leader in the technology sector, Sterne Kessler helps clients develop comprehensive IP solutions that protect innovation, foster growth, and maximize value. Whether you are an emerging startup company or a well-established technology pioneer, we are committed to helping you harness the full potential of AI technology.
Pharmaceutical Patent Litigation
At Sterne Kessler, we know what it takes to win across any venue in pharmaceutical IP litigation. Our award-winning team has a deep bench of experienced litigators representing biosimilars as well as generic and specialty brand pharmaceutical companies in high-profile patent litigation, including blockbuster Abbreviated New Drug Application (ANDA) and Biologics Price Competition and Innovation Act (BPCIA) matters.
ITC Litigation
With one of the nation’s top ITC practices, Sterne Kessler offers unrivaled experience, comprehensive litigation strategy, and the legal and technical know-how to achieve the best possible results. In the last five years, Sterne Kessler has handled more cases at the ITC than 90% of firms appearing before the Commission.
Design Patents
For nearly four decades, Sterne Kessler has been at the forefront of design patents, consistently delivering successful outcomes for clients in securing and defending their design rights. We develop effective, comprehensive IP programs to protect some of the most iconic product designs in the world and to eliminate knock-offs in the marketplace.
Featured News
More News & Insights
Sterne Kessler Scores Patent Reexamination Win for Equilibrium—All Claims Upheld
Washington, D.C. (July 8, 2025) – Sterne, Kessler, Goldstein & Fox announces that it has successfully defended Equil IP Holdings (d/b/a Equilibrium) in an ex parte reexamination (Case…
Why You Need to Protect Your AI-Based Inventions
Spurred by artificial intelligence, the aerospace industry is poised to rapidly accelerate the pace of tech development. Companies that fail to safeguard their AI-based inventions stand to miss…
Sterne Kessler and 13 Directors Earn Top Rankings in Managing IP’s 2025 “IP Stars” Guide
Washington, D.C. (June 30, 2025) – Sterne, Kessler, Goldstein & Fox is honored to announce that Managing IP has ranked the firm and 13 directors among the best…
Sterne Kessler Shoots Down IPR Petition for Lone Star Future Weapons
Washington, D.C. (June 27, 2025) – Sterne, Kessler, Goldstein & Fox secured a denial of an inter partes review (IPR) petition at the U.S. Patent and Trademark Office…
Sterne Kessler Awarded “Top Workplaces” Recognition from The Washington Post for the 12th Consecutive Year
Washington, D.C. (June 23, 2025) – Sterne, Kessler, Goldstein & Fox is pleased to announce that the firm has been named among the “Top Workplaces” in the Greater…
IP Hot Topic: The (Media) Empire Strikes Back
Some of the largest movie studios have entered the fray of GenAI copyright litigation. Disney, Marvel, Lucasfilm, Twentieth Century Fox, Universal Pictures, and DreamWorks sued the image-GenAI company…
Latest Director Discretionary Denial Decision in iRhythm Provides Valuable Insights
On June 6, 2025, Acting USPTO Director Stewart issued a decision in iRhythm Tech. v. Welch Allyn, Inc., IPR2025-00363, Paper 10 (and four related IPRs), which granted Patent…
Sterne Kessler Recognized for Key Practice Areas, Remains the Only Band 1 Firm for Patent Prosecution in D.C.
Washington, D.C. (June 6, 2025) – Sterne, Kessler, Goldstein & Fox has been recognized as a leading firm by Chambers USA 2025, earning the only Band 1 firm…
Sterne Kessler and 18 Directors Earn High Marks in the 2025 IAM Patent 1000
Washington, D.C. (June 3, 2025) – Sterne, Kessler, Goldstein & Fox is once again recognized among the nation’s top intellectual property law firms in the 2025 IAM Patent…
Your innovations are worth the best protection
Expertise
Sterne Kessler is a full-service IP firm that delivers innovative solutions tailored to your business and industry.